» Articles » PMID: 33282599

Mesenteric Artery Thrombosis, Microvascular Intestinal Endothelitiis, and Guillain-Barrè Syndrome in the Same SARS-CoV-2 Patient

Overview
Journal Cureus
Date 2020 Dec 7
PMID 33282599
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Coronavirus disease 2019 (COVID-19) in humans is a novel disease that can affect every organ of the body, with life-threatening consequences. Microvascular lesions and thrombosis have been previously reported in the lung, kidney, and brain. We report a case of combined intestinal lesions and Guillain-Barrè Syndrome in a patient suffering from COVID-19 in the absence of clear laboratory predictors of upcoming complications. The patient survived the severe respiratory syndrome but died after virus-related systemic organ failure.

Citing Articles

Guillain-Barré Syndrome in the COVID-19 Pandemic.

Tawakul A, Al-Doboke A, Altayyar S, Alsulami S, Alfahmi A, Nooh R Neurol Int. 2022; 14(1):34-48.

PMID: 35076589 PMC: 8788454. DOI: 10.3390/neurolint14010003.


Guillain Barré syndrome associated with COVID-19- lessons learned about its pathogenesis during the first year of the pandemic, a systematic review.

Freire M, Andrade A, Sopena B, Lopez-Rodriguez M, Varela P, Cacabelos P Autoimmun Rev. 2021; 20(8):102875.

PMID: 34119673 PMC: 8191287. DOI: 10.1016/j.autrev.2021.102875.

References
1.
Gattinoni L, Coppola S, Cressoni M, Busana M, Rossi S, Chiumello D . COVID-19 Does Not Lead to a "Typical" Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2020; 201(10):1299-1300. PMC: 7233352. DOI: 10.1164/rccm.202003-0817LE. View

2.
Varga Z, Flammer A, Steiger P, Haberecker M, Andermatt R, Zinkernagel A . Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020; 395(10234):1417-1418. PMC: 7172722. DOI: 10.1016/S0140-6736(20)30937-5. View

3.
Wada H, Matsumoto T, Yamashita Y . Diagnosis and treatment of disseminated intravascular coagulation (DIC) according to four DIC guidelines. J Intensive Care. 2014; 2(1):15. PMC: 4267589. DOI: 10.1186/2052-0492-2-15. View

4.
Gazzaruso C, Carlo Stella N, Mariani G, Nai C, Coppola A, Naldani D . High prevalence of antinuclear antibodies and lupus anticoagulant in patients hospitalized for SARS-CoV2 pneumonia. Clin Rheumatol. 2020; 39(7):2095-2097. PMC: 7251560. DOI: 10.1007/s10067-020-05180-7. View

5.
Leisman D, Deutschman C, Legrand M . Facing COVID-19 in the ICU: vascular dysfunction, thrombosis, and dysregulated inflammation. Intensive Care Med. 2020; 46(6):1105-1108. PMC: 7186535. DOI: 10.1007/s00134-020-06059-6. View